UB Paderborn / Katalog / Suche / in CDI

Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas

Gastroenterology (New York, N.Y. 1943), 2002-10, Vol.123 (4), p.1052-1060

2002

Volltextzugriff (PDF)

Secretion of MUC5AC mucin from pancreatic cancer cells in response to forskolin and VIP

Biochemical and biophysical research communications, 2002-06, Vol.294 (3), p.680-686

2002

Volltextzugriff (PDF)

Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: Its relationship with a new morphological classification of cholangiocarcinoma

Hepatology (Baltimore, Md.), 1999-12, Vol.30 (6), p.1347-1355

1999

Volltextzugriff (PDF)

Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells

International journal of oncology, 2003-02, Vol.22 (2), p.273

2003

Volltextzugriff (PDF)

Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors

Cancer, 1993-04, Vol.71 (7), p.2191-2199

1993

Volltextzugriff (PDF)

MUC3 human intestinal mucin. Analysis of gene structure, the carboxyl terminus, and a novel upstream repetitive region

The Journal of biological chemistry, 1997-10, Vol.272 (42), p.26678-26686

1997

Volltextzugriff (PDF)

Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils

International journal of oncology, 2002-09, Vol.21 (3), p.649

2002

Volltextzugriff (PDF)

E‐selectin binding by pancreatic tumor cells is inhibited by cancer sera

International journal of cancer, 1994-06, Vol.57 (6), p.901-907

1994

Volltextzugriff (PDF)

Antibody‐dependent Cytotoxicity Mediated by Chimeric Monoclonal Antibody Nd2 and Experimental Immunotherapy for Pancreatic Cancer

Cancer science, 2000-08, Vol.91 (8), p.817-824

2000

Volltextzugriff (PDF)

Intrahepatic Ductal Hypoplasia and Anomalous Junction of pancreatico-biliary ductal system as causes of choledocal cysts

Gastroenterology (New York, N.Y. 1943), 2001-04, Vol.120 (5), p.A387-A387

2001

Volltextzugriff (PDF)

Phorbol Ester Reduces Phosphorylation of Epidermal Growth Factor Receptor in Pancreatic Cancer Cells by Activation of a Tyrosine Phosphatase

Biochemical and biophysical research communications, 1999-11, Vol.265 (3), p.728-733

1999

Volltextzugriff (PDF)

Access to Peptide Regions of a Surface Mucin (MUC1) Is Reduced by Sialic Acids

Biochemical and biophysical research communications, 1995-05, Vol.210 (3), p.866-873

1995

Volltextzugriff (PDF)

Biliopancreatic malignancy: Future prospects for progress

Annals of oncology, 1999, Vol.10 (suppl-4), p.S300-S304

1999

Volltextzugriff (PDF)

Serological pancreatic tumor markers and the MUC1 apomucin

Pancreas, 1994-11, Vol.9 (6), p.674-691

1994

Volltextzugriff (PDF)

Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins

Cancer research (Chicago, Ill.), 1991-02, Vol.51 (3), p.1026-1033

1991

Volltextzugriff (PDF)

The detection of human pancreatic cancer‐associated antigen in the serum of cancer patients

Cancer, 1987-10, Vol.60 (7), p.1636-1643

1987

Volltextzugriff (PDF)

Monoclonal antibody directed against colon cancer mucin has high specificity for malignancy

International journal of cancer, 1993-05, Vol.54 (3), p.467-474

1993

Volltextzugriff (PDF)

Expression of mucin‐associated tumor antigens is altered by cell density

International journal of cancer, 1997-07, Vol.72 (3), p.457-466

1997

Volltextzugriff (PDF)

Multiple forms of intracellular and secreted mucins in a pancreatic cancer cell line

Cancer research (Chicago, Ill.), 1993-02, Vol.53 (4), p.884-890

1993

Volltextzugriff (PDF)

Intratumoral Injection of an Adriamycin Immunoconjugate against Human Pancreatic Cancer Xenografts

Cancer science, 1995-11, Vol.86 (11), p.1072-1079

1995

Volltextzugriff (PDF)

Differences in expression of SPan‐1 and CA15‐3 antigens in blood and tissues

International journal of cancer, 1992-11, Vol.52 (5), p.693-700

1992

Volltextzugriff (PDF)

Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin

Cancer research (Chicago, Ill.), 1991, Vol.51 (1), p.372-380

1991

Volltextzugriff (PDF)

Tumor Localization and Biodistribution with Radiolabeled Monoclonal Anbibody against Pancreatic Cancer in Tumor-Bearing Nude Mice

Tohoku journal of experimental medicine, 1992, Vol.168 (2), p.397-401

1992

Volltextzugriff (PDF)

Expression of CA19-9, DU-PAN-2, and SPan-1 antigens on two types of normal salivary mucins

Oncology research, 1993, Vol.5 (9), p.347

1993

Volltextzugriff (PDF)

Human pancreatic cancer-associated antigens detected by murine monoclonal antibodies

Cancer research (Chicago, Ill.), 1985-12, Vol.45 (12), p.6179-6186

1985

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas

Secretion of MUC5AC mucin from pancreatic cancer cells in response to forskolin and VIP

Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: Its relationship with a new morphological classification of cholangiocarcinoma

Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells

Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors

MUC3 human intestinal mucin. Analysis of gene structure, the carboxyl terminus, and a novel upstream repetitive region

Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils

E‐selectin binding by pancreatic tumor cells is inhibited by cancer sera

Antibody‐dependent Cytotoxicity Mediated by Chimeric Monoclonal Antibody Nd2 and Experimental Immunotherapy for Pancreatic Cancer

Intrahepatic Ductal Hypoplasia and Anomalous Junction of pancreatico-biliary ductal system as causes of choledocal cysts

Phorbol Ester Reduces Phosphorylation of Epidermal Growth Factor Receptor in Pancreatic Cancer Cells by Activation of a Tyrosine Phosphatase

Access to Peptide Regions of a Surface Mucin (MUC1) Is Reduced by Sialic Acids

Biliopancreatic malignancy: Future prospects for progress

Serological pancreatic tumor markers and the MUC1 apomucin

Relationship of pancreatic cancer apomucin to mammary and intestinal apomucins

The detection of human pancreatic cancer‐associated antigen in the serum of cancer patients

Monoclonal antibody directed against colon cancer mucin has high specificity for malignancy

Expression of mucin‐associated tumor antigens is altered by cell density

Multiple forms of intracellular and secreted mucins in a pancreatic cancer cell line

Intratumoral Injection of an Adriamycin Immunoconjugate against Human Pancreatic Cancer Xenografts

Differences in expression of SPan‐1 and CA15‐3 antigens in blood and tissues

Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin

Tumor Localization and Biodistribution with Radiolabeled Monoclonal Anbibody against Pancreatic Cancer in Tumor-Bearing Nude Mice

Expression of CA19-9, DU-PAN-2, and SPan-1 antigens on two types of normal salivary mucins

Human pancreatic cancer-associated antigens detected by murine monoclonal antibodies

Suchergebnisse filtern